Alembic Pharmaceuticals, an Indian pharmaceutical company, rebounded on Monday, gaining 4% after reaching a 52-week low last week...
Pfizer has sold its rights to a nearly 54-acre land parcel in the Trans-Thane Creek Industrial Area (TTCIA) near Mumbai to Vidhi Research & Development LLP for more than Rs 207 crore, including a differential premium to the Maharashtra Industrial...
Nutraceutical manufacturers are companies that produce and distribute nutraceuticals, which are products that contain bioactive compounds derived from food sources. These products are often marketed as dietary supplements and are belie
Walmart plans to add more than a dozen healthcare facilities to some of its stores next year as it expands its focus on basic care and other services. The company stated that it will establish 28 centres in 2024, the majority of which will be in....
Akums Drugs and Pharmaceutical Limited has declared its entry into the nutraceutical gummies market with a new line of formulations for wellness and prevalent ailments. This effort aims to address a variety of conditions by providing a solution for..
Irene Pharma, a leading pharmaceutical manufacturing company in Ahmedabad, Gujarat, India, focuses on providing the most nutritional value possible through a diverse range of high-quality healthcare products. The company's high-tech manufacturing....
Mukesh Ambani's group is venturing into genetic mapping, hoping to make a healthcare trend spearheaded by disruptive US startups like 23andMe more affordable and widespread in India's expanding consumer market...
Bristol Myers Squibb (BMS) has become the latest drug maker to announce its intent to set up a state-of-the-art centre in India to support its global drug development, digital innovation and technology plans...
AstraZeneca India has declared its entry into the Indian market for rare disease therapy. The regulatory approval of its 'Selumetinib' shows the company's commitment to bringing first-in-class, science-based therapies to patients in India...
Zydus Lifesciences said it has received approval from the US health regulator to market a generic medication to prevent and treat blood clots. The company has received approval from the US Food and Drug Administration (USFDA) to market Apixaban...
, CDSCO.jpg)
